Scantox Group
Martin Amtoft-Christensen is an experienced financial executive currently serving as Chief Financial Officer at Scantox Group since May 2022. Previously held positions include Interim CFO at Columbus A/S, Group CFO at De Forenede Dampvaskerier A/S and Allianceplus A/S, and various leadership roles at Berendsen, where responsibilities spanned across the Nordic region and included membership on the Executive Board. Early career experience includes Group CFO at BITĖ Group and Financial Director at TDC Group. Martin Amtoft-Christensen holds an MSc in Economics from Aarhus University along with several executive education qualifications from institutions such as INSEAD and The Wharton School.
Scantox Group
Scantox is a contract research organization that specializing in pharmacology and regulatory toxicology services. Their preclinical contract research services enable clients to progress their drug or device development. They offer various contract research services such as safety pharmacology, exploratory, and endotoxin testing.